Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Afamelanotide is authorised as a medicine in certain jurisdictions
Track your injections and vial usage
GLP-1 receptor agonists have shown strong efficacy in promoting weight loss and improving glycemic control, making them a preferred choice for patients with obesity, type 2 diabetes, and cardiovascular risk factors
Most patients who have type II diabetes or prediabetes will get coverage from their health insurance plans
Il ne faut pas oublier cependant que les injections doivent tre refaites tous les 2 4 mois
About TRIUMPH-4 and the TRIUMPH clinical trial program TRIUMPH-4 (NCT05869903) is a Phase 3, 68-week, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of retatrutide with placebo in adults with obesity or overweight and knee osteoarthritis
US$ 21.98
US$ 28.86
US$ 24.58
US$ 29.71
US$ 27.63
US$ 25.02
US$ 26.25
